The rating on senior secured notes issued by Biocon Biologics Global PLC was also upgraded to ‘BB+.’
Hongene will focus on developing and scaling production of key capping reagents—essential components of mRNA therapeutics—emphasizing accessibility, transparency, and global deployment
Under the deal, ViiV Healthcare will issue new shares to Shionogi for $2.125 billion and cancel Pfizer’s holding
LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
The guidelines also support reusing tenofovir and abacavir in later regimens for improved outcomes, cost savings, and programmatic efficiency
India’s pharmaceutical sector stands at a pivotal inflection point
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
Subscribe To Our Newsletter & Stay Updated